Johnson & Johnson (JNJ.F)
- Previous Close
138.36 - Open
138.78 - Bid 136.80 x 30000
- Ask 137.08 x 30000
- Day's Range
136.72 - 140.00 - 52 Week Range
134.00 - 160.40 - Volume
1,545 - Avg. Volume
969 - Market Cap (intraday)
332.342B - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
19.78 - EPS (TTM)
6.95 - Earnings Date Jul 17, 2024
- Forward Dividend & Yield 4.67 (3.37%)
- Ex-Dividend Date May 20, 2024
- 1y Target Est
--
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
www.jnj.com131,900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: JNJ.F
Performance Overview: JNJ.F
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JNJ.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JNJ.F
Valuation Measures
Market Cap
334.42B
Enterprise Value
340.41B
Trailing P/E
19.93
Forward P/E
13.91
PEG Ratio (5yr expected)
0.89
Price/Sales (ttm)
4.56
Price/Book (mrq)
5.19
Enterprise Value/Revenue
4.16
Enterprise Value/EBITDA
15.18
Financial Highlights
Profitability and Income Statement
Profit Margin
47.37%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
85.65B
Net Income Avi to Common (ttm)
19.17B
Diluted EPS (ttm)
6.95
Balance Sheet and Cash Flow
Total Cash (mrq)
22.93B
Total Debt/Equity (mrq)
44.25%
Levered Free Cash Flow (ttm)
--
Company Insights: JNJ.F
JNJ.F does not have Company Insights